| Total (n = 729) | Without postoperative AKI (n = 541) | With postoperative AKI (n = 188) | P value | Preoperative albumin ≥37.5 g/La (n = 456) | Preoperative albumin < 37.5 g/La (n = 273) | P value |
---|---|---|---|---|---|---|---|
Age (y) | 67 ± 16 | 66 ± 16 | 71 ± 14 | < 0.001 | 66 ± 15 | 69 ± 14 | 0.056 |
Male sex | 432 (59.3%) | 318 (58.8%) | 114 (60.6%) | 0.655 | 276 (60.5%) | 156 (57.1%) | 0.368 |
BMI (kg/m2) | 24.1 ± 4.5 | 24.0 ± 4.6 | 24.6 ± 4.4 | 0.139 | 24.7 ± 4.3 | 23.2 ± 4.7 | < 0.001 |
Preoperative comorbidities | |||||||
 Diabetes mellitus | 194 (26.6%) | 136 (25.1%) | 58 (30.9%) | 0.127 | 123 (27.0%) | 71 (26.0%) | 0.775 |
 Hypertension | 399 (54.7%) | 287 (53.0%) | 112 (59.6%) | 0.122 | 260 (57.0%) | 139 (50.9%) | 0.109 |
 Coronary heart disease | 195 (26.7%) | 138 (25.5%) | 57 (30.3%) | 0.199 | 130 (28.5%) | 65 (23.8%) | 0.165 |
 Congestive heart failure | 23 (3.2%) | 14 (2.6%) | 9 (4.8%) | 0.133 | 13 (2.9%) | 10 (3.7%) | 0.544 |
 Cerebrovascular disease | 140 (19.2%) | 99 (18.3%) | 41 (21.8%) | 0.293 | 94 (20.6%) | 46 (16.8%) | 0.212 |
 Chronic kidney disease | 23 (3.2%) | 9 (1.7%) | 14 (7.4%) | < 0.001 | 8 (1.8%) | 15 (5.5%) | 0.005 |
 Lung disease b | 68 (9.3%) | 51 (9.4%) | 17 (9.0%) | 0.876 | 41 (9.0%) | 27 (9.9%) | 0.686 |
 Liver disease c | 20 (2.7%) | 16 (3.0%) | 4 (2.1%) | 0.548 | 10 (2.2%) | 10 (3.7%) | 0.240 |
 Malignant neoplasm | 474 (65.0%) | 349 (64.5%) | 125 (66.5%) | 0.624 | 247 (65.1%) | 177 (64.8%) | 0.935 |
 Peripheral vascular disease | 37 (5.1%) | 24 (4.4%) | 13 (6.9%) | 0.182 | 21 (4.6%) | 16 (5.9%) | 0.455 |
ASA classification |  | < 0.001 |  | < 0.001 | |||
 I | 12 (1.6%) | 12 (2.2%) | 0 (0.0%) |  | 7 (1.5%) | 5 (1.8%) |  |
 II | 275 (37.7%) | 224 (41.4%) | 51 (27.1%) |  | 202 (44.3%) | 73 (26.7%) |  |
 III | 404 (55.4%) | 284 (52.5%) | 120 (63.8%) |  | 238 (52.2%) | 166 (60.8%) |  |
 IV | 38 (5.2%) | 21 (3.9%) | 17 (9.0%) |  | 9 (2.0%) | 29 (10.6%) |  |
Preoperative Hb (g/L) d | 124 ± 23 | 125 ± 22 | 119 ± 26 | 0.007 | 133 ± 18 | 108 ± 23 | < 0.001 |
Preoperative albumin (g/L) d | 38.6 ± 6.2 | 39.3 ± 6.0 | 36.7 ± 6.3 | < 0.001 | 42.5 ± 3.0 | 32.1 ± 4.2 | < 0.001 |
Preoperative albumin < 37.5 g/L | 273 (37.4%) | 175 (32.3%) | 98 (52.1%) | < 0.001 | __ | __ | __ |
Baseline serum creatinine (umol/L) e | 80.4 ± 26.3 | 78.2 ± 22.2 | 86.7 ± 35.1 | 0.002 | 81.5 ± 23.6 | 78.5 ± 30.4 | 0.163 |
Preoperative BNP (pg/ml) f | 98 (43, 190) | 84 (38, 166) | 126 (61, 220) | 0.001 | 66 (31, 133) | 140 (72, 257) | < 0.001 |
Radiocontrast exposure g | 76 (10.4%) | 48 (8.9%) | 28 (14.9%) | 0.020 | 44 (9.6%) | 32 (11.7%) | 0.375 |
On ACEI/ARB | 62 (8.5%) | 48 (8.9%) | 14 (7.4%) | 0.546 | 38 (8.3%) | 24 (8.8%) | 0.830 |
Smoking habit h | 136 (18.7%) | 108 (20.0%) | 28 (14.9%) | 0.124 | 94 (20.6%) | 42 (15.4%) | 0.079 |